Key result
MyoRobot 3.0 reveals ~27% fiber area loss during stretch and calcium-dependent increases in passive stiffness.
Why the study?
Accurate assessment of single muscle fibre biomechanics requires integrated structural and functional analysis, but conventional approaches assume constant fibre geometry during passive stretch and interchangeably use continuous stress-strain and stepwise stretch-jump protocols.
The MyoRobot 3.0 platform corrects major structural sources of error in single muscle fibre biomechanical analysis by tracking diameter changes during stretch.
May require diameter corrections in fibre stiffness assays; leaves open translation to cardiac mechanics.
Accurate assessment of biomechanical properties in single muscle fibres requires integrated structural and functional analysis. Conventional approaches assume constant fibre geometry during passive stretch and often use continuous stress–strain and stepwise stretch‐jump protocols interchangeably, despite their differing mechanical implications. We introduce the MyoRobot 3.0 , a next‐generation biomechatronics platform that integrates automated force measurements with fibre‐wide optical imaging. By synchronising a motorized optical system with controlled stretch velocities, the device maintains a constant field of view during elongation, enabling continuous diameter tracking along the same fibre segment. Using this approach, we quantified diameter thinning during axial stretch and compared slow continuous stress–strain recordings with rapid stepwise stretch‐jumps under varying calcium conditions and with or without cross‐bridge inhibition. Fibre diameter decreased by 13–15% at 40% strain, resulting in 27% cross‐sectional area loss and systematic underestimation of restoration stress when uncorrected. Continuous stress–strain protocols revealed calcium‐dependent increases in passive stiffness, whereas stepwise stretch‐jumps did not, indicating that the apparent calcium sensitivity partially reflects viscous or time‐dependent contributions. The MyoRobot 3.0 corrects major structural sources of error and enables protocol‐resolved biomechanical analysis, improving interpretation of passive muscle stiffness and its molecular determinants.
No takes yet. Share an insight, caveat, or question.
Haug et al. (2026) studied this question. MyoRobot 3.0 platform vs. Conventional approaches was evaluated on Fibre diameter thinning during axial stretch and passive stiffness. Using the MyoRobot 3.0, single muscle fibre diameter decreased by 13–15% at 40% strain, resulting in 27% cross-sectional area loss and revealing calcium-dependent increases in passive stiffness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: